Stockholm Stock Exchange | Large Cap
Vitrolife
+58.95%
Latest
+38.22%
3 months
DNB CarnegieSEBCarnegieSEB EquitiesHandelsbankenDNBHandelsbanken Capital MarketsDNB Markets

Price Targets For Vitrolife

AnalystPrice TargetDateUpside
DNB Carnegie230 SEKOct 1
+58.95%
SEB170 SEKSep 23
Carnegie265 SEKMar 20
SEB Equities275 SEKOct -24
Handelsbanken250 SEKJul -24
DNB250 SEKJul -24
Handelsbanken Capital Markets220 SEKJan -24
DNB Markets220 SEKJan -24

About The Company

Vitrolife is a Swedish medtech company which sells products for IVF treatment.
Wikipedia